M
Martyn Plummer
Researcher at International Agency for Research on Cancer
Publications - 99
Citations - 26167
Martyn Plummer is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 50, co-authored 92 publications receiving 22767 citations. Previous affiliations of Martyn Plummer include University of Cambridge.
Papers
More filters
JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling
TL;DR: JAGS is a program for Bayesian Graphical modelling which aims for compatibility with Classic BUGS and could eventually be developed as an R package.
CODA: convergence diagnosis and output analysis for MCMC
TL;DR: Bayesian inference with Markov Chain Monte Carlo with coda package for R contains a set of functions designed to help the user answer questions about how many samples are required to accurately estimate posterior quantities of interest.
Journal ArticleDOI
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
Catherine de Martel,Jacques Ferlay,Silvia Franceschi,Jérôme Vignat,Freddie Bray,David Forman,Martyn Plummer +6 more
TL;DR: Application of existing public health methods for infection prevention, such as vaccination, safer injection practice, or antimicrobial treatments, could have a substantial effect on the future burden of cancer worldwide.
Journal ArticleDOI
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis.
TL;DR: A majority of ICC was associated with HPV16 or 18 in all regions, but approximately a quarter of all ICC cases were associated with one of 16 other HPV types, their distribution varying by region.
Journal ArticleDOI
Global burden of human papillomavirus and related diseases.
David Forman,Catherine de Martel,Charles J.N. Lacey,Isabelle Soerjomataram,Joannie Lortet-Tieulent,Laia Bruni,Jérôme Vignat,Jacques Ferlay,Freddie Bray,Martyn Plummer,Silvia Franceschi +10 more
TL;DR: Cervical cancer is the third most common female malignancy and shows a strong association with level of development, rates being at least four-fold higher in countries defined within the low ranking of the Human Development Index (HDI) compared with those in the very high category.